NCT00723255 2019-07-23
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southern California
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)